Wednesday, 23rd October Australasian RNA Biology and Biotechnology Association 2024 Conference

• Uncovering the spatial complexity of transcriptomics: localised photoreceptor stress as modulator of retinal vasculature - Ulrike Schumann
• Early Embryonic Cell Fate Decisions directed by Differential RNA Localisation and Translation - Jennifer Zenker
• Unveiling the Critical Role of the RNA editing enzyme ADAR1p110 in Postnatal Development and Survival - Zhen Liang
• SOX6-regulated L1 retrotransposon activity expands the neuronal transcriptome - Gabriela O Bodea

• Extracellular vesicle and RNA biomarkers in colorectal cancer: addressing clinical questions and exploring functions - Kirsty Danielson
• Paraspeckles and paraspeckle building blocks: the roles of RNA and RNA binding proteins in phase separation and disease - Archa Fox
• Circular RNA dependencies of oncogenic signalling - Matt Neve
• Isoform-specific perturb-seq reveals alternative promoter dynamics in gene regulation and drug response - Helen E King
• A specific variant of NL02, a brain-enriched lncRNA, regulates lysosomal function in human neurons - Indranil Basak

Archa Fox Presentation sponsored by:

• mRNA vaccination: Directing T cell immunity to where it is needed - William Heath
• Synthetic messenger RNA delivery in healthy liver, liver disease and cancer - Laura Leighton
• Antisense Oligonucleotide mediated reduction of C9ORF72 expansion containing transcripts in IPSC-derived motor neurons - Ianthe Pitout
• Therapeutic efficacy of antisense oligonucleotides in humanized preclinical mouse model of inherited childhood-lethal neurodegenerative disorder - Raman Sharma
• GWAS-empowered characterization of a primate-specific long non-coding RNA gene as a causal contributor to, and a sequence-based drug target in, human type 2 diabetes: insights from a nonhuman primate model - Leonard Lipovich

• Australia’s RNA Footprint – historical highlights and a look into the future - Thomas Preiss
• Discovery and validation of alternative splicing driven novel targets and therapeutics for ALS, leveraging AI/ML - Gayatri Arun